NewAmsterdam Pharma Company N.V.
NAMS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$242 | -$177 | -$23 | -$42 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $34 | $0 | $4 | $1 |
| Change in WC | -$33 | $6 | $10 | $4 |
| Other Non-Cash | $82 | $30 | $19 | $7 |
| Operating Cash Flow | -$159 | -$141 | $11 | -$30 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$62 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$63 | -$0 | -$0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $1 | $0 |
| Stock Issued | $646 | $9 | $397 | $85 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $14 | $0 | -$6 | $0 |
| Financing Cash Flow | $660 | $9 | $392 | $85 |
| Forex Effect | -$7 | $5 | $5 | -$5 |
| Net Chg. in Cash | $431 | -$127 | $408 | $50 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $340 | $468 | $60 | $10 |
| End Cash | $772 | $340 | $468 | $60 |
| Free Cash Flow | -$159 | -$141 | $10 | -$30 |